Sangamo Therapeutics
SGMO
#10417
Rank
C$43.21 M
Marketcap
C$0.10
Share price
0.00%
Change (1 day)
-84.35%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : C$0.11 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total liabilities are C$0.11 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Sangamo Therapeutics - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$0.10 B-10.44%
2024-12-31C$0.11 B3.51%
2023-12-31C$0.10 B-69.88%
2022-12-31C$0.36 B-17.8%
2021-12-31C$0.44 B-21.48%
2020-12-31C$0.56 B110.33%
2019-12-31C$0.26 B-12.01%
2018-12-31C$0.30 B144.6%
2017-12-31C$0.12 B326.21%
2016-12-31C$29.15 M-15.24%
2015-12-31C$34.39 M-18.97%
2014-12-31C$42.44 M108.48%
2013-12-31C$20.36 M16.1%
2012-12-31C$17.53 M139.33%
2011-12-31C$7.32 M3.37%
2010-12-31C$7.08 M-56.97%
2009-12-31C$16.47 M8.79%
2008-12-31C$15.14 M28.88%
2007-12-31C$11.74 M42.64%
2006-12-31C$8.23 M-36.65%
2005-12-31C$13 M361.09%
2004-12-31C$2.82 M38.39%
2003-12-31C$2.03 M-34.87%
2002-12-31C$3.12 M-26.39%
2001-12-31C$4.25 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
C$168.76 B 151,582.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$117.45 B 105,467.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.26 B 13,624.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
C$60.64 B 54,407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$46.30 B 41,520.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$116.66 B 104,758.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$5.71 B 5,037.06%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$3.35 B 2,914.33%๐Ÿ‡บ๐Ÿ‡ธ USA